MIMETAS
MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlates featuring organotypic screening models that have an improved predictability and can be screened at a high throughput.
MIMETAS
Industry:
3D Technology Biotechnology Health Care Information Technology
Founded:
2013-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.mimetas.com
Total Employee:
101+
Status:
Active
Contact:
(318) 588-8316
Email Addresses:
[email protected]
Total Funding:
32.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network JsDelivr Facebook Sharer Amazon Virginia Region Pardot LiveChat Lighttpd
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Mimetas
European Life Sciences Growth Fund
European Life Sciences Growth Fund investment in Series B - Mimetas
OostNL
OostNL investment in Series B - Mimetas
Cathay Venture
Cathay Venture investment in Series B - Mimetas
Korys
Korys investment in Series B - Mimetas
InnovationQuarter
InnovationQuarter investment in Series B - Mimetas
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Series B - Mimetas
PMV
PMV investment in Series A - Mimetas
Zeeuws Investerings Fonds
Zeeuws Investerings Fonds investment in Series A - Mimetas
Official Site Inspections
http://www.mimetas.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.93 K
- Host name: 104.21.16.16
- IP address: 104.21.16.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mimetas"
Human Tissue Models for Better Therapies - MIMETAS
Discover our mission, vision, company history, and core values that drive innovation at MIMETAS. Using our OrganoCore ® Discovery Platform, we create robust and screenable assays for …See details»
MIMETAS - Wikipedia
Mimetas is a privately owned biotechnology company developing human organ-on-a-chip tissue models and products for drug development. The company also is involved in the testing of chemicals along with food and personalized medicine applications. The company is based in Oegstgeest and Enschede, The Netherlands, with subsidiairies in Gaithersburg (MD), United States, and Tokyo, Japan. Mimetas was founded in 2011 by Paul Vulto, Jos Joore, Bas Trietsch and Th…See details»
About Us - MIMETAS
MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds. As an extension of your team, MIMETAS provides the expertise and resources needed for effective research …See details»
Services - MIMETAS
MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds. As an extension of your team, MIMETAS provides the expertise and …See details»
MIMETAS - LinkedIn
By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to...See details»
MIMETAS Company Profile 2024: Valuation, Funding
Developer of organ-on-a-chip products designed for compound testing, screening, and fundamental research.See details»
Mimetas - Crunchbase Company Profile & Funding
MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient.See details»
MIMETAS - LinkedIn
By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative …See details»
Mimetas B.V. | Scientist.com
As true pioneers in organ-on-a-chip biology, MIMETAS is proud to offer high-throughput human tissue and disease models in OrganoPlates®. OrganoPlates® are microfluidic 3D culture plates, supporting up to 96 tissue models on a …See details»
MIMETAS Elected Most Innovative Company of the …
As the 2022 award winner, MIMETAS succeeds ASML, today’s global leader in semiconductor equipment and Europe’s largest high-tech company. MIMETAS (Leiden, The Netherlands) is a global leader in human-relevant disease …See details»
MIMETAS: QMUL Centre for Predictive in vitro Models
MIMETAS is a global leader in human tissue and disease modeling, using its organ-on-a-chip technology to develop physiologically relevant 3D in vitro models without the need of …See details»
Future Organ-on-a-chip Global Leader MIMETAS raised 4 Million …
Oct 13, 2014 · Dutch biotech MIMETAS B.V. announces that it has raised 4 Million euros ($5.2M) to fund its expansion as a global leader in organ-on-a-chip technology.See details»
Mimetas - Lifesciences @ Work
As true pioneers in organ-on-a-chip biology, we are proud to develop any-throughput human tissue and disease models in the OrganoPlate ® for the industry. Our vision is to create the …See details»
MIMETAS - Technology Networks
MIMETAS strives to contribute to groundbreaking therapies with unique human disease biology, revealed by robust, screenable assays in the most versatile technology platform. By combining …See details»
MIMETAS - Human Tissue Models for Better Therapies - YouTube
MIMETAS' OrganoPlate® serves as an early stage screening model to predict toxic side effects and drug efficacy.See details»
Team - MIMETAS
MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds. As an extension of your team, MIMETAS provides the expertise and …See details»
MIMETAS and Astellas Enter into Strategic Partnership on Immuno ...
Mar 28, 2023 · MIMETAS, a human disease model provider, entered into a strategic partnership with Astellas Pharma Inc. The partnership comprises utilizing MIMETAS’ comprehensive …See details»
MIMETAS organ-on-a-chip technology
OrganoPlate ® is a microfluidic 3D tissue culture plate, supporting up to 96 tissue models on a single plate. Its unique PhaseGuide tm technology enables cells to interact and migrate freely …See details»
Partners and projects with Mimetas involvement — Mimeta
Jun 13, 2024 · In 2020 we will hopefully be able to provide organizational support to our established partners in MENA and Africa South of Sahara so that they will be able to continue …See details»
Mimeta
Mimetas vision is to give GIVE PEOPLE THEIR RIGHT TO FREE CREATIVE EXPRESSIONS, created on free terms and presented by independent institutions. Our mission is to support and …See details»